A β-Targeting Strategy: V24P(10–40) and Conjugates for Amyloid Sequestration in Alzheimer’s Models

by Rawamino | Oct 29, 2025 | Peptides

Introduction Alzheimer’s disease (AD) remains defined by progressive cognitive decline, synaptic failure, and characteristic proteinopathies that include extracellular amyloid-β (Aβ) deposits and intraneuronal tau aggregates. The “amyloid cascade” framework posits...

Curcumin-PLGA Nanocarriers for Amyloid Pathways, Neuroinflammation, and Adult Neurogenesis in Alzheimer’s Research

by Rawamino | Oct 29, 2025 | Peptides

Introduction Alzheimer’s disease (AD) is marked by network-level cognitive decline emerging from convergent cellular stressors, including proteostasis failure (Aβ and tau misfolding), chronic neuroinflammatory signaling, synaptic dysfunction, and impaired adult...

Investigating the Cdk5i Peptide: Targeting Cdk5/p25 Interactions in Alzheimer’s-Related Neurodegeneration

by Rawamino | Oct 29, 2025 | Peptides

Introduction Biochemical analyses indicated that Cdk5i binds more strongly to the Cdk5/p25 complex than to Cdk5 alone, reflecting its targeted affinity for the pathological form of the kinase. Alzheimer’s disease (AD) represents a complex neurodegenerative disorder...

Molecular Insights into Buntanetap: A Translational Inhibitor Targeting Neurotoxic Protein Synthesis in Experimental Neurodegeneration

by Rawamino | Oct 28, 2025 | Peptides

Introduction Protein misfolding and aggregation are central pathological features in neurodegenerative disorders, contributing to cellular toxicity, synaptic loss, and chronic neuroinflammation. Experimental models of Alzheimer’s disease (AD) and Parkinson’s disease...

Fraternine and Venom-Derived Peptides: Experimental Neuroprotection of Dopaminergic Circuits in Parkinsonian Models

by Rawamino | Oct 28, 2025 | Peptides

Introduction Parkinson’s disease (PD) is characterized by progressive degeneration of midbrain dopaminergic neurons and the emergence of motor and non-motor features that substantially impair function. Converging evidence suggests a multifactorial etiology in which...

Cell-Penetrating Peptides, JNK Signaling, and Experimental Strategies to Limit Neuronal Loss

by Rawamino | Oct 27, 2025 | Peptides

Introduction Neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) emerge from intersecting processes—proteostasis failure, maladaptive stress signaling, metabolic compromise, and inflammation—that culminate in progressive neuronal...